SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

$COCK.X is trending due to the launch of Cocky Wings LLC, a real-world business selling chicken wings, which aims to drive revenue for token buybacks. The community is excited about the potential of a meme coin with real-world utility, with many highlighting the connection to the Cardano chain ($ADA.X).

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses potential price targets and its role in the Real World Asset (RWA) narrative. The recent partnership with the U.S. Department of Commerce to provide economic data on-chain has generated excitement, with many believing this could signal further adoption by governments and institutions.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as its community rallies around its fair launch and Bitcoin-native nature, contrasting it with other meme coins. Community members are actively discussing its potential to outperform Dogecoin and its strong connection to the Bitcoin network. There's also excitement surrounding potential exchange listings and the involvement of C2 Blockchain.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as traders discuss its potential as a hedge against market downturns and a way to profit from an expected decrease in the Dow Jones. The community highlights its appeal as a Bitcoin-native memecoin with a fair launch and strong community support. Some traders are comparing it to Dogecoin ($DOGE) and touting its potential to "flip" DOGE, while others are considering it for downside protection amid economic uncertainty.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending due to speculation around a potential licensing deal with AstraZeneca and positive momentum from its lung cancer drug, Ivonescimab, currently in Phase III trials. Community discussions revolve around the drug's efficacy, trial data, and the possibility of a buyout, with some skepticism about the company's valuation in the absence of FDA approval. The stock's volatile price action and high short interest are also fueling discussions among investors.

This isn’t just another token. $RISK is a symbol, a call to the fearless, the dream-chasers, the ones who know that greatness only comes to those who are willing to leap.  Born from the legendary phrase “risk it for the biscuit,” $RISK is a tribute to boldness. It’s made for those who refuse to settle, who thrive on high-stakes moments, and who would rather go all in than live with the regret of playing it safe.  In the world of $RISK, there are no participation trophies. You either take the shot or you miss the opportunity.  This token represents a lifestyle, the mindset that: 	•	Playing it safe never made legends. 	•	Caution doesn’t make history. 	•	Only the bold get rewarded.

ItForTheBiscuit

ItForTheBiscuit (RISK.X) is trending amid community excitement surrounding its team and recent technical breakouts. Discussions highlight strong community conviction and potential for further growth, with some focusing on chart patterns suggesting positive momentum. The project's fundamentals and its potential within the broader meme coin landscape are also being actively discussed.

"Founded by OS expert Rong Chen, Elastos is building the blockchain industry’s most comprehensive and interoperable open source platform. Using a hybrid consensus that combines the secure hashpower of Bitcoin and the democratic ideals of Delegated-Proof-of-Stake, the SmartWeb of Elastos is a suite of software for an entirely decentralized internet. Elastos employs not only blockchain technology, but a peer-to-peer network for communication, decentralized data storage services, and a decentralized ID (DID) system for all digital assets. With sidechains like Ethereum, Elastos is not merely the foundation for securing truly decentralized applications that can scale, it is the foundation for true data ownership.   elastOS, the flagship product of the Elastos Smartweb, brings the entire decentralized ecosystem into a single App, currently available for Android and in development for both iOS and desktop.  Elastos is also actively searching for both new and existing dApp projects through its Cyber Republic initiative. Cyber Republic possesses a community-governed grant fund designed to help startups and existing businesses explore blockchain. You can read more about Cyber Republic at https://www.cyberrepublic.org.

Elastos

Elastos is trending as community members discuss its potential as a Bitcoin Layer 2 solution and speculate on future price movements, with some anticipating a significant run. Recent integration news and its limited token supply are also fueling interest. However, some traders are wary of its historical price action and dependence on broader market trends.

MYX Finance

MYX Finance is trending as traders actively discuss potential shorting opportunities, particularly above the $2.20 price level. The conversation includes speculation about possible token unlocks and their impact on price, with some warning against shorting while others anticipate a significant price decrease. Community members are sharing trading plans and technical analysis, focusing on potential entry and exit points for short positions.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

IDYA is trending following positive Phase 2 data and FDA discussion regarding registrational trial design for darovasertib in uveal melanoma, with the community focused on the potential for accelerated approval. Community members are also excited about the potential of the company's pipeline and multiple upcoming catalysts. Bullish sentiment is further supported by analyst upgrades and reiterated buy ratings.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

Fueled by news of a land sale agreement potentially boosting NAV, Gyrodyne is trending as traders discuss its low float and potential for a significant squeeze. Community members are closely watching key breakout levels, anticipating a rapid price increase if momentum continues. The stock's historical volatility and potential for a meme-driven rally are also contributing to the current buzz.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tylenol maker Kenvue (KVUE) dropped to a one-year low in afternoon trade on Friday after reports surfaced that Health Secretary Robert F. Kennedy Jr. intends to link prenatal use of the drug to autism.<a href="http://stocktwits.com/symbol/KVUE">Kenvue’s stock</a> tumbled more than&nbsp;13%&nbsp;to&nbsp;$17.77, its lowest level since&nbsp;July 2024. On Stocktwits, retail sentiment around the company fell into ‘bearish’ territory from ‘neutral’ over the past day.&nbsp;Friday’s drop brings Kenvue’s year-to-date loss to over 17%. The stock has fallen 21% over the past 12 months.According to a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/health/healthcare/rfk-jr-hhs-to-link-autism-to-tylenol-use-in-pregnancy-and-folate-deficiencies-e3acbb4c">report</a> by The Wall Street Journal, the Department of Health and Human Services (HHS) is likely to release its findings later this month. The upcoming Health Department report is expected to link autism risk to low folate levels and Tylenol use during pregnancy, people familiar with the matter told the publication.Tylenol is made by McNeil Consumer Healthcare, a division of Kenvue, though other companies also sell acetaminophen-based products. The active ingredient in Tylenol is acetaminophen, which is widely used as a pain reliever, including by pregnant women.&nbsp;The report said that research on its impact during pregnancy has produced mixed results. It cited that the American College of Obstetricians and Gynecologists found Tylenol to be safe for use during pregnancy. However, it advises women to consult with their doctors before taking any medication.Kennedy, meanwhile, has long promised to reveal the cause of autism. “By September, we will know what has caused the autism epidemic,” he&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bbc.com/news/articles/cj0z9nmzvdlo">said</a> during an April cabinet meeting with President Donald Trump.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bessent-says-fed-must-change-course-to-preserve-independence/chwI13sRdqQ">Bessent Reportedly Says Fed Must Change Course To Preserve Independence</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tylenol, which contains acetaminophen, is offered for sale at a drug store on April 14, 2015 in Chicago, Illinois. (Photo by Scott Olson/Getty Images)

Kenvue Stock Hits One-Year Low After Report Says HHS Will Link Tylenol Use In Pregnancy To Autism Risk

According to a report by The Wall Street Journal, the Department of Health and Human Services is likely to release its findings later this month. 

Equity

J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?

Johnson & Johnson stock surges above key moving averages as strong results, raised guidance and growth prospects fuel momentum.

Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Kenvue (KVUE) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Kenvue (KVUE) Q2 Earnings Top Estimates

Kenvue (KVUE) delivered earnings and revenue surprises of +3.57% and -0.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Edgewell Personal Care (EPC) Misses Q3 Earnings and Revenue Estimates

Edgewell Personal (EPC) delivered earnings and revenue surprises of -8.91% and -4.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

The broader market reversed on Monday, recovering from the steep losses witnessed on Friday, on hopes of an&nbsp;interest rate cut. The Dow Industrials jumped nearly 600 points,&nbsp;and small-cap stocks outperformed the broader market, with the Russell 2000 Index increasing by 2.10%.Amid the rise in risk appetite, the S&amp;P 500 Index snapped a four-session decline, ending 1.47% higher.Earnings news continues to drive market activity, with more updates expected on Tuesday.<a href="https://stocktwits.com/symbol/PLTR">Palantir Technologies (PLTR)</a>After-hours move: +4.57%Trading volume: 17.39 millionPalantir stock took off in after-hours trading on Monday after the company reported a solid quarterly beat and raised its full-year guidance. Investors cheered the Alex-Karp-led company’s first-ever billion-dollar revenue quarter.&nbsp;Retail users of the Stocktwits platform relished the results, with sentiment flipping to ‘extremely bullish’ by late Monday from ‘bearish’ a day ago. The message volume also lifted to ‘extremely high’ levels.&nbsp;Palantir stock, which was up over 112% year-to-date by Monday’s close, is on track to hit fresh highs on Tuesday.<a href="https://stocktwits.com/symbol/KVUE">Kenvue (KVUE)</a>After-hours move: +1.22%Trading volume: 14.20 millionKenvue stock has been on investors’ radar as the consumer health company spun off from Johnson &amp; Johnson faces fundamental issues. The company has recently undergone a change in leadership and has also initiated a strategic review process.&nbsp;The stock gained momentum ahead of the company’s second-quarter results, due on Thursday before the market opens. Fiscal.ai-compiled consensus puts the company’s earnings per share (EPS) and revenue at $0,28 and $3.85 billion, respectively. This marks a decline from the year-ago $0.32 and $4 billion, respectively.&nbsp;The company is the maker of renowned healthcare product brands such as Tylenol and Band-Aid.On Stocktwits, retail sentiment toward the stock continues to languish at a ‘bearish’ level, with the message volume remaining ‘low.’Kenvue stock is up about 6% this year.<a href="https://stocktwits.com/symbol/AAPL">Apple (AAPL)</a>After-hours move: -0.05%Trading volume: 12.71 millionApple’s blowout third-quarter results did not ignite a rally in the stock as the soft July non-farm payrolls report played a spoilsport on Friday. The stock did not gain enough momentum on Monday, despite the broader market rally. The muted reaction reflected investor concerns about the impact of Trump tariffs and Apple's lag in adopting artificial intelligence.Bloomberg’s Mark Gurman said on Sunday that Apple is working on a stripped-down version of a standalone app, similar to ChatGPT, in-house.Apple stock is down 18.60% this year, despite the broader market gaining over 8%. Retail traders, however, are upbeat, with Stocktwits sentiment meter showing a reading relaying an ‘extremely bullish’ mood.<a href="https://stocktwits.com/symbol/INTC">Intel (INTEL)</a>After-hours move: flatTrading volume: 9.65 millionShares of struggling chipmaker Intel also saw brisk trading volumes in Monday’s extended hours. Late Monday, rating agency Fitch downgraded Intel’s “Long-Term Issuer Default Rating” (IDR) and senior unsecured ratings to 'BBB' from 'BBB+,' and affirmed its “Short-Term IDR and commercial paper rating at 'F2'. The Rating Outlook was set at Negative.The rating agency stated that the actions reflected its view that the demand environment would be more challenging than previously anticipated, thereby constraining profitability growth. It also expects the credit metrics to remain weak.Intel shares continued to attract ‘bearish’ sentiment among users of the Stocktwits platform, with the sour mood accompanied by ‘low’ volumes.The stock is down nearly 2.5% this year.<a href="https://stocktwits.com/symbol/NVDA">Nvidia (NVDA)</a>After-hours move: +0.37%Trading volume: 9.14 millionNvidia shares recovered from Friday’s sell-off and ended Monday’s session up 3.62% at $180, a record closing high. The stock, however, could not go past its intraday high of $183.30 in Monday’s session.The stock is likely to continue its winning run on Tuesday, thanks to Palantir’s strong results and Cathie Wood’s Ark Invest snapping up more than 23,000 Nvidia shares.Retail sentiment toward Nvidia stock tempered slightly to ‘bullish’ from ‘extremely bearish’ a day ago. The message volume remained at ‘high’ levels.The stock has gained a whopping 34% this year.The Jensen Huang-led company, which is riding high on its near-monopoly position in the AI chip market, is scheduled to report its quarterly results on Aug. 27. Traders may read the tea leaves from AI chip peer AMD’s (AMD) results due Tuesday after the market close and the management commentary.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-jones-nasdaq-futures-rise-on-palantir-boost-rate-cut-hopes/chrLW9YRdcg">Dow Jones, Nasdaq Futures Rise On Palantir Boost, Rate Cut Hopes — Trump Promises 'Many More Days Like This' In Stock Market</a>

Traders work on the floor of the New York Stock Exchange during afternoon trading on August 01, 2025 in New York City. (Photo by Michael M. Santiago/Getty Images)

Palantir, Kenvue, Apple, Intel, Nvidia: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Amid the rise in risk appetite, the S&P 500 Index snapped a four-session decline, ending 1.47% higher.

Countdown to Kenvue (KVUE) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Besides Wall Street's top-and-bottom-line estimates for Kenvue (KVUE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

U.S. stocks retreated in the final session of an otherwise solid&nbsp;July as traders remained apprehensive ahead of President Donald Trump’s tariff deadline and the monthly non-farm payrolls report.Earnings news continued to catalyze trading in Thursday’s after-hours session, and the following stocks were the most actively traded ones in the extended session:<a href="https://stocktwits.com/symbol/AAPL">Apple (AAPL)</a>After-hours move: +2.42%Trading volume: 22.27 millionApple shares rose in extended trading after the tech giant reported its fastest revenue growth since the December quarter of 2021, driven by unexpectedly strong iPhone sales&nbsp;as customers reportedly rushed to snap up the devices before Trump’s tariffs kicked in. CEO Tim Cook&nbsp;also pledged to ramp up its artificial intelligence (AI) investment as&nbsp;Cupertino plays catch-up.On Stocktwits, sentiment toward Apple stock shifted to ‘extremely bullish’ (81/100) by late Thursday, up from the ‘neutral’ mood seen a day prior. The message volume perked up to ‘extremely high’ levels.Apple stock has lost nearly 17% this year, ahead of the earnings report.<a href="https://stocktwits.com/symbol/AMZN">Amazon (AMZN)</a>After-hours move: -6.62%Trading volume: 21.37 millionThe after-hours slide in Amazon’s shares came after the e-commerce giant reported roughly in-line revenue for its Amazon Web Services (AWS). The year-over-year (YoY) growth of the Cloud business came in at 18%, slower than that of Alphabet and Microsoft's rival units.The company’s operating income guidance for the third quarter also did not go down well with investors.&nbsp;The Andy Jassy-led company, however, reported forecast-beating second-quarter results.Retail investors on Stocktwits turned more optimistic, with the sentiment meter showing a reading corresponding to ‘extremely bullish’ levels (90/100) by late Thursday, up from ‘bullish’ a day ago. The message volume also turned ‘extremely high.’For the year-to-date period, Amazon shares have gained about 6.7%, underperforming the broader market.<a href="https://stocktwits.com/symbol/NVDA">Nvidia (NVDA)</a>After-hours move: -0.66%Trading volume: 13.38 millionNvidia stock fell 0.78% in Thursday’s regular session after a Reuters report said China expressed concerns about security risks in using Nvidia’s H20 China-compliant AI chip. The negative close was despite the stock hitting an intraday record earlier in this session, inspired by positive earnings reports from Meta and Microsoft.After the Trump administration imposed curbs on the export of H20 chips to China in April, Nvidia’s CEO, Jensen Huang, announced last month that the U.S. had given&nbsp;assurances it would allow the resumption of the exports.&nbsp;Nvidia reportedly&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-denies-claims-of-backdoor-access-amid-chinese-security-inquiry/choLWN7RdG2">clarified</a> that it does not have "backdoors" in its chips and won't allow backdoor access to its systems.The weakness may also be attributed to broader market concerns stemming from geopolitical issues.The sentiment toward Nvidia stock tempered to ‘bullish’ (73/100) from the ‘extremely bullish’ mood seen a day ago. The message volume stayed at ‘high’ levels.<a href="https://stocktwits.com/symbol/INTC">Intel (INTEL)</a>After-hours move: -0.25%Trading volume: 9.3 millionIntel shares fell 2.65% in Thursday’s regular session amid ongoing news about austerity measures. Ohio Governor Mike DeWine reportedly said earlier this week that he spoke to Intel CEO Lip-Bu Tan and is confident that the chipmaker will successfully&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.statenews.org/government-politics/2025-07-30/dewine-says-intel-ceo-is-very-optimistic-about-ohio-plant-but-that-dates-are-up-in-the-air">build out</a> the now-delayed $28 billion chip manufacturing facility northeast of Columbus.Bloomberg reported, citing people familiar with the matter, that Ericsson AB was planning to&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-31/ericsson-in-talks-to-invest-in-intel-standalone-network-business">invest</a> hundreds of billions of dollars in Intel’s networking infrastructure business.On Stocktwits, sentiment toward Intel stock nose-dived to ‘bearish’ (34/100) from ‘extremely bullish’ a day ago.Intel shares are down about 1.25% year-to-date.<a href="https://stocktwits.com/symbol/KVUE">Kenvue (KVUE)</a>After-hours move: +0.28%Trading volume: 6.36 millionShares of consumer health company Kenvue, a spin-off from Johnson &amp; Johnson, fell sharply in June before making a comeback last month. In mid-July, the maker of Tylenol and Band-Aid replaced its CEO, Thibaut Mongon, with Kirk Perry on an interim basis.&nbsp;The company also stated at that time that it had formed an independent committee to oversee a review of strategic alternatives that it initiated earlier this year.Kenvue announced a 1.2% increase to its quarterly dividend Wednesday morning, but the stock reacted negatively to the announcement.Retail traders on Stocktwits continued to hold a ‘bearish’ sentiment toward the stock, with the message volume at ‘normal’ levels.Kenvue stock has risen a modest 2.30% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-slaps-reciprocal-tariffs-up-to-41-as-deadline-expires/chr3jMCRdGh">Trump Slaps Reciprocal Tariffs Up To 41% As Deadline Expires — Canada, Transshipped Goods Emerge As Key Targets</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on May 19, 2025, in New York City. Stocks were down sharply as traders react to Moody's downgrading the United States' credit rating. 

Apple, Amazon, Nvidia, Intel, Kenvue: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Apple shares climbed in extended trading after surprisingly strong iPhone sales helped the tech giant report its fastest revenue growth since the December quarter of 2021.

Analysts Estimate Kenvue (KVUE) to Report a Decline in Earnings: What to Look Out for

Kenvue (KVUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should J&J Stock Be in Your Portfolio After Q2 Beat & Guidance Raise?

JNJ jumps over 6% on Q2 earnings beat and full-year guidance increase, driven by strong pharma sales and improved MedTech sales.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Current Price	$18.60
Prev Close	$20.54
Open	$20.51
Dividend Yield	3.79%
50-Day Moving Average	$21.37
Beta	0.00
Avg. Volume	16.96M
PE Ratio	25.30

52-Week High	$25.17
52-Week Low	$17.15
Market Capitalization	$35.73B
EPS (Annual)	$0.5382
Price to Book	3.33
Revenue Per Employee	$702,545.45
Enterprise Value/EBITDA	N/A

KVUE
Kenvue Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KVUE News

KVUE Kenvue Inc